Evidence map›Paper›PMID 25793476›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2015

The flagellar protein FLAG1/SMP1 is a candidate for Leishmania-sand fly interaction.

Tatiana Di-Blasi, Amanda R Lobo, Luanda M Nascimento, Jose L Córdova-Rojas, Karen Pestana, Marcel Marín-Villa, Antonio J Tempone, Erich L Telleria, Marcelo Ramalho-Ortigão, Diane McMahon-Pratt and 1 more

Abstract read
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. RNAi-mediated gene silencing ofFrontiers in physiology · 2023
    Article
  5. Microorganisms · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tatiana Di-Blasi1 Laboratório de Biologia Molecular de Parasitas e Vetores, Instituto Oswaldo Cruz , FIOCRUZ, Rio de Janeiro, RJ, Brazil .
Amanda R Lobo
Luanda M Nascimento
Jose L Córdova-Rojas
Karen Pestana
Marcel Marín-Villa
Antonio J Tempone
Erich L Telleria
Marcelo Ramalho-Ortigão
Diane McMahon-Pratt
Yara M Traub-Csekö

Funding

Improved Treatment of American Cutaneous Leishmaniasis by ImmunomodulationR01AI093775 · NIAID · YALE UNIVERSITY · PI GORE SARAVIA, NANCY, MCMAHON PRATT, DIANE · 2011 to 2014
$2.6M
STUDIES OF DIFFERENTIALLY EXPRESSED LEISHMANIA ANTIGENSR01AI027811 · NIAID · YALE UNIVERSITY · PI MCMAHON PRATT, DIANE · 1989 to 2008
$2.0M
NIAID NIH HHS R01 AI027811NIAID NIH HHS R01 AI093775
6 · The paper itself

Abstract

Leishmaniasis is a serious problem that affects mostly poor countries. Various species of Leishmania are the agents of the disease, which take different clinical manifestations. The parasite is transmitted by sandflies, predominantly from the Phlebotomus genus in the Old World and Lutzomyia in the New World. During development in the gut, Leishmania must survive various challenges, which include avoiding being expelled with blood remnants after digestion. It is believed that attachment to the gut epithelium is a necessary step for vector infection, and molecules from parasites and sand flies have been implicated in this attachment. In previous work, monoclonal antibodies were produced against Leishmania. Among these an antibody was obtained against Leishmania braziliensis flagella, which blocked the attachment of Leishmania panamensis flagella to Phlebotomus papatasi guts. The protein recognized by this antibody was identified and named FLAG1, and the complete FLAG1 gene sequence was obtained. This protein was later independently identified as a small, myristoylated protein and called SMP1, so from now on it will be denominated FLAG1/SMP1. The FLAG1/SMP1 gene is expressed in all developmental stages of the parasite, but has higher expression in promastigotes. The anti-FLAG1/SMP1 antibody recognized the flagellum of all Leishmania species tested and generated the expected band by western blots. This antibody was used in attachment and infection blocking experiments. Using the New World vector Lutzomyia longipalpis and Leishmania infantum chagasi, no inhibition of attachment ex vivo or infection in vivo was seen. On the other hand, when the Old World vectors P. papatasi and Leishmania major were used, a significant decrease of both attachment and infection were seen in the presence of the antibody. We propose that FLAG1/SMP1 is involved in the attachment/infection of Leishmania in the strict vector P. papatasi and not the permissive vector L. longipalpis.

Indexed as

Amino Acid SequenceAnimalsBlotting, WesternFluorescent Antibody TechniqueGene Expression RegulationHost-Parasite InteractionsLeishmaniaMolecular Sequence DataPhylogenyProtozoan ProteinsPsychodidaeProtozoan ProteinsFLAG1/SMP1FlagellumLeishmaniaLeishmaniasisLutzomyia longipalpisPhlebotomus papatasiSand flyVector–parasite interaction

Identifiers

PMID25793476
PMCPMC4939454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.